CMIC Holdings Co Ltd - ESG Rating & Company Profile powered by AI
This assessment of CMIC Holdings Co Ltd was prepared by All Street Sevva using cutting edge NLP. Alternative corporations in the rating peer group for CMIC Holdings Co Ltd are displayedin the table. The page displays a zero-cost E,S&G report covering CMIC Holdings Co Ltd.
CMIC Holdings Co Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
0.0
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1967 | Hospira Inc | 0.3 | Low |
1967 | PRA Health Sciences Inc | 0.3 | Low |
1970 | CMIC Holdings Co Ltd | 0.0 | Low |
1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
1970 | CTC Bio Inc | 0.0 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does CMIC Holdings Co Ltd have an accelerator or VC vehicle to help deliver innovation?
Does CMIC Holdings Co Ltd disclose current and historical energy intensity?
Does CMIC Holdings Co Ltd report the average age of the workforce?
Does CMIC Holdings Co Ltd reference operational or capital allocation in relation to climate change?
Does CMIC Holdings Co Ltd disclose its ethnicity pay gap?
Does CMIC Holdings Co Ltd disclose cybersecurity risks?
Does CMIC Holdings Co Ltd offer flexible work?
Does CMIC Holdings Co Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does CMIC Holdings Co Ltd disclose the number of employees in R&D functions?
Does CMIC Holdings Co Ltd conduct supply chain audits?
Does CMIC Holdings Co Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does CMIC Holdings Co Ltd conduct 360 degree staff reviews?
Does CMIC Holdings Co Ltd disclose the individual responsible for D&I?
Does CMIC Holdings Co Ltd disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does CMIC Holdings Co Ltd disclose current and / or historical scope 2 emissions?
Does CMIC Holdings Co Ltd disclose water use targets?
Does CMIC Holdings Co Ltd have careers partnerships with academic institutions?
Did CMIC Holdings Co Ltd have a product recall in the last two years?
Does CMIC Holdings Co Ltd disclose incidents of discrimination?
Does CMIC Holdings Co Ltd allow for Work Councils/Collective Agreements to be formed?
Has CMIC Holdings Co Ltd issued a profit warning in the past 24 months?
Does CMIC Holdings Co Ltd disclose parental leave metrics?
Does CMIC Holdings Co Ltd disclose climate scenario or pathway analysis?
Does CMIC Holdings Co Ltd disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does CMIC Holdings Co Ltd disclose the pay ratio of women to men?
Does CMIC Holdings Co Ltd support suppliers with sustainability related research and development?
Does CMIC Holdings Co Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does CMIC Holdings Co Ltd reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is CMIC Holdings Co Ltd involved in embryonic stem cell research?
Does CMIC Holdings Co Ltd disclose GHG and Air Emissions intensity?
Does CMIC Holdings Co Ltd disclose its waste policy?
Does CMIC Holdings Co Ltd report according to TCFD requirements?
Does CMIC Holdings Co Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does CMIC Holdings Co Ltd disclose energy use targets?
Does CMIC Holdings Co Ltd disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does CMIC Holdings Co Ltd have a policy relating to cyber security?
Have a different question?
Potential Risks for CMIC Holdings Co Ltd
These potential risks are based on the size, segment and geographies of the company.
CMIC HOLDINGS Co., Ltd. provides various services for the pharmaceutical industry in Japan. The company operates in five segments: Contract Research Organization, Contract Development and Manufacturing Organization, Contract Sales Organization, Healthcare, and Innovative Pharma Model. It offers clinical trial services, including clinical operations and trials, data management, clinical caretaker, medical writing, patient recruitment, pharmacovigilance, project management, audit and quality assurance, and statistical analysis; and clinical site network, CMC, drug development, health economics and outcome research, market entry/out-licensing, medical devices and in vitro diagnostic consulting, medical writing, national health insurance pricing, and product life cycle management consulting services. The company also provides development and manufacturing services, including commercial supply, contract development and manufacturing, investigational product manufacturing, packaging and labeling, release and stability tests, technology transfer, as well as formulation, process, and analytical development services; and laboratory services, such as bioanalysis and GLP analysis, biomarkers, CMC and GMP analysis, large molecule, oligonucleotides, small molecule, and toxicity, as well as safety pharmacology, in vitro and in vivo, and non-clinical studies. In addition, it offers patient and healthcare services, such as drug adherence support program, harmo, Helc+, prescription drug database, and selcheck services; and post-marketing surveillance, self-inspection, regulatory affairs consulting, regulatory submissions and correspondence, sales and marketing, clinical research coordinating, clinical site administration, and site management services. CMIC HOLDINGS Co., Ltd. has a partnership with Science 37, Inc. to decentralize clinical trials and enhance the development of treatments. The company was incorporated in 1985 and is headquartered in Tokyo, Japan.